US 11786605
Site specific antibody-drug conjugates with peptide-containing linkers
granted A61KA61K2039/505A61K38/07
Quick answer
US patent 11786605 (Site specific antibody-drug conjugates with peptide-containing linkers) held by Mersana Therapeutics, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K38/07, A61K47/545, A61K47/65